サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1560955

移植診断市場レポート：成分、技術、臓器タイプ、用途、エンドユーザー、地域別、2024年～2032年

Transplant Diagnostics Market Report by Component, Technology, Organ Type, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
移植診断市場レポート：成分、技術、臓器タイプ、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

移植診断市場の世界市場規模は2023年に8億7,370万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに17億900万米ドルに達し、2024年から2032年の間に7.5％の成長率（CAGR）を示すと予測しています。

移植診断は、臓器移植や造血幹細胞移植の組織適合性や免疫遺伝学の基礎となるものです。臓器提供者候補とレシピエント候補の適合性判定においてヘルスケア専門家を支援します。臓器の生存率を高めると同時に、重篤な移植合併症を最小限に抑えることができます。その結果、病理学、免疫遺伝学、感染症、分子診断学、治療薬モニタリング、ヒト白血球抗原（HLA）タイピングおよびモニタリングなど、さまざまな分野で利用されています。

移植診断市場動向：

加工食品の消費量の増加、タバコやアルコール摂取者の増加により、急性および慢性疾患の有病率が増加しており、臓器不全の症例数が著しく増加しています。このことは、血液提供者数の増加と相まって、ドナーとレシピエントの適合性を確保し、移植患者のQOLを向上させるために、世界の移植診断の需要を促進する主な要因の一つとなっています。さらに、高齢者は健康上の問題や臓器不全に陥りやすいため、世界の老人人口の増加が市場成長に寄与しています。深刻な交通事故や衝突事故の増加も、臓器移植とその診断の需要に影響を与えています。これとは別に、メーカー各社は抗体検出製品、検査機器、コンピューターソフトウェアを包括的に提供しています。これらの製品は、検査手順や最終的な検査評価を簡素化・自動化するために活用され、良好な市場見通しを生み出しています。さらに、数カ国の政府によるヘルスケア分野への支出増加が市場成長を後押ししています。さらに、複数のヘルスケア企業が臨床および研究開発用途の革新的で高品質なHLA製品の開発に注力しており、これが市場を牽引すると予測されています。

本レポートで扱う主な質問

  • 世界の移植診断市場はこれまでどのように推移し、今後どのように推移していくのか？
  • COVID-19は世界の移植診断市場にどのような影響を与えたか？
  • 主要地域市場とは？
  • 成分別の市場内訳は？
  • 技術別の市場内訳は？
  • 臓器タイプ別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の移植診断市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の移植診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：コンポーネント別

  • 機器と設備
    • 市場動向
    • 市場予測
  • 試薬および消耗品
    • 市場動向
    • 市場予測
  • ソフトウェアとサービス
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • 非分子アッセイ
    • 市場動向
    • 主要セグメント
      • 血清学的検査
      • 混合リンパ球培養
    • 市場予測
  • 分子アッセイ
    • 市場動向
    • 主要セグメント
      • PCベース
      • シーケンスベース
    • 市場予測

第8章 市場内訳：臓器タイプ別

  • 腎臓
    • 市場動向
    • 市場予測
  • 肝臓
    • 市場動向
    • 市場予測
  • 心臓
    • 市場動向
    • 市場予測
  • 肺
    • 市場動向
    • 市場予測
  • 膵臓
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：用途別

  • 移植前診断
    • 市場動向
    • 市場予測
  • 移植後診断
    • 市場動向
    • 市場予測

第10章 市場内訳：エンドユーザー別

  • 病院と移植センター
    • 市場動向
    • 市場予測
  • 研究ラボおよび学術機関
    • 市場動向
    • 市場予測
  • 商用サービスプロバイダー
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Hologic Inc
    • Illumina Inc.
    • Immucor Inc.（IVD Holdings Inc.）
    • Merck KGaA
    • Qiagen N.V.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Transplant Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Transplant Diagnostics Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Transplant Diagnostics Market: Breakup by Component (in %), 2023
  • Figure 5: Global: Transplant Diagnostics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Transplant Diagnostics Market: Breakup by Organ Type (in %), 2023
  • Figure 7: Global: Transplant Diagnostics Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Transplant Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Transplant Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Transplant Diagnostics (Instrument and Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Transplant Diagnostics (Instrument and Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Transplant Diagnostics (Reagent and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Transplant Diagnostics (Reagent and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Transplant Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Transplant Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Transplant Diagnostics (Non-Molecular Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Transplant Diagnostics (Non-Molecular Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Transplant Diagnostics (Molecular Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Transplant Diagnostics (Molecular Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Transplant Diagnostics (Kidney) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Transplant Diagnostics (Kidney) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Transplant Diagnostics (Liver) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Transplant Diagnostics (Liver) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Transplant Diagnostics (Heart) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Transplant Diagnostics (Heart) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Transplant Diagnostics (Lung) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Transplant Diagnostics (Lung) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Transplant Diagnostics (Pancreas) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Transplant Diagnostics (Pancreas) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Transplant Diagnostics (Other Organ Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Transplant Diagnostics (Other Organ Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Transplant Diagnostics (Pre-Transplant Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Transplant Diagnostics (Pre-Transplant Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Transplant Diagnostics (Post-Transplant Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Transplant Diagnostics (Post-Transplant Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Transplant Diagnostics (Hospitals and Transplant Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Transplant Diagnostics (Hospitals and Transplant Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Transplant Diagnostics (Research Laboratories and Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Transplant Diagnostics (Research Laboratories and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Transplant Diagnostics (Commercial Service Providers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Transplant Diagnostics (Commercial Service Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: North America: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: North America: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: United States: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: United States: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Canada: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Canada: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Asia-Pacific: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Asia-Pacific: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: China: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: China: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Japan: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Japan: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: India: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: India: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: South Korea: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: South Korea: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Australia: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Australia: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Indonesia: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Indonesia: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Europe: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Europe: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Germany: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Germany: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: France: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: France: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: United Kingdom: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: United Kingdom: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Italy: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Italy: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Spain: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Spain: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Russia: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Russia: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Latin America: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Latin America: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Brazil: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Brazil: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Mexico: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Mexico: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Middle East and Africa: Transplant Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Middle East and Africa: Transplant Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 90: Middle East and Africa: Transplant Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Global: Transplant Diagnostics Industry: SWOT Analysis
  • Figure 92: Global: Transplant Diagnostics Industry: Value Chain Analysis
  • Figure 93: Global: Transplant Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transplant Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transplant Diagnostics Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Transplant Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Transplant Diagnostics Market Forecast: Breakup by Organ Type (in Million US$), 2024-2032
  • Table 5: Global: Transplant Diagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Transplant Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Transplant Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Transplant Diagnostics Market: Competitive Structure
  • Table 9: Global: Transplant Diagnostics Market: Key Players
目次
Product Code: SR112024A4436

The global transplant diagnostics market size reached US$ 873.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,709.0 Million by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.

Transplant diagnostics are the basis for histocompatibility and immunogenetics of organ and hematopoietic stem cell transplantations. They assist healthcare professionals in determining the compatibility between potential organ donors and recipients. They increase the chances of organ survival while minimizing serious transplant complications. As a result, they are used in various disciplines, such as pathology, immunogenetics, infectious diseases, molecular diagnostics, therapeutic drug monitoring, and human leukocyte antigens (HLA) typing and monitoring.

Transplant Diagnostics Market Trends:

The growing prevalence of acute and chronic diseases on account of the increasing consumption of processed food products and the escalating number of individuals that smoke tobacco products and consume alcohol is causing a significant rise in the number of organ failure cases. This, in confluence with the growing number of blood donors, represents one of the primary factors driving the demand for transplant diagnostics worldwide to ensure donor-recipient compatibility and improve the quality of life of transplant patients. Moreover, as older people are more prone to health problems and organ failure, the rising geriatric population across the globe is contributing to market growth. The escalating number of severe road accidents or collisions is also influencing the demand for organ transplantation and its diagnostics. Apart from this, manufacturers are offering a comprehensive range of antibody detection products, laboratory instrumentation, and computer software. These products can be utilized to simplify and automate testing procedures and final test evaluations, which is creating a favorable market outlook. Furthermore, the increasing expenditure in the healthcare sector by governments of several countries is impelling the market growth. Furthermore, several healthcare firms are focusing on developing innovative, high-quality HLA products for clinical and research applications, which, in turn, is projected to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transplant diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, technology, organ type, application and end user.

Breakup by Component:

  • Instrument and Equipment
  • Reagent and Consumables
  • Software and Services

Breakup by Technology:

  • Non-Molecular Assay
    • Serological Assay
    • Mixed Lymphocyte Culture
  • Molecular Assay
    • PC-based
    • Sequencing-based

Breakup by Organ Type:

  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
  • Others

Breakup by Application:

  • Pre-Transplant Diagnostics
  • Post-Transplant Diagnostics

Breakup by End User:

  • Hospitals and Transplant Centers
  • Research Laboratories and Academic Institutes
  • Commercial Service Providers

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Hologic Inc, Illumina Inc., Immucor Inc. (IVD Holdings Inc.), Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global transplant diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global transplant diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the component?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the organ type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global transplant diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transplant Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Instrument and Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagent and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Non-Molecular Assay
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Serological Assay
      • 7.1.2.2 Mixed Lymphocyte Culture
    • 7.1.3 Market Forecast
  • 7.2 Molecular Assay
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 PC-based
      • 7.2.2.2 Sequencing-based
    • 7.2.3 Market Forecast

8 Market Breakup by Organ Type

  • 8.1 Kidney
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liver
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Heart
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Lung
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Pancreas
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Pre-Transplant Diagnostics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Post-Transplant Diagnostics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals and Transplant Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research Laboratories and Academic Institutes
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Commercial Service Providers
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 bioMerieux SA
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 F. Hoffmann-La Roche AG
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 SWOT Analysis
    • 16.3.6 Hologic Inc
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Illumina Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Immucor Inc. (IVD Holdings Inc.)
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 SWOT Analysis
    • 16.3.9 Merck KGaA
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Qiagen N.V.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Thermo Fisher Scientific Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis